U.S. Continuous Glucose Monitoring Devices Market Size, Share, & Trends Report

U.S. Continuous Glucose Monitoring Devices Market Size, Share, & Trends Analysis Report By Component (Transmitters, Sensors, Receivers), By End-use (Hospitals, Homecare), By Connectivity (Bluetooth, 4G), And Segment Forecasts, 2024 - 2030

  • Report ID: GVR-4-68040-235-3
  • Number of Report Pages: 100
  • Format: PDF, Horizon Databook
  • Historical Range: 2018 - 2022
  • Forecast Period: 2024 - 2030 
  • Industry: Healthcare

Table of Contents

Chapter 1. Methodology and Scope
                      1.1. Market Segmentation & Scope
                      1.2. Segment Definitions
                          1.2.1. Component
                          1.2.2. Connectivity
                          1.2.3. End-use
                          1.2.4. Estimates and forecasts timeline
                      1.3. Research Methodology
                      1.4. Information Procurement
                          1.4.1. Purchased database
                          1.4.2. GVR’s internal database
                          1.4.3. Secondary sources
                          1.4.4. Primary research
                          1.4.5. Details of primary research
                              1.4.5.1. Data for primary interviews in Italy
                      1.5. Information or Data Analysis
                          1.5.1. Data analysis models
                      1.6. Market Formulation & Validation
                      1.7. Model Details
                          1.7.1. Commodity flow analysis (Model 1)
                          1.7.2. Approach 1: Commodity flow approach
                          1.7.3. Volume price analysis (Model 2)
                          1.7.4. Approach 2: Volume price analysis
                      1.8. List of Secondary Sources
                      1.9. List of Primary Sources
                      1.10. Objectives
Chapter 2. Executive Summary
                      2.1. Market Outlook
                      2.2. Segment Outlook
                          2.2.1. Component
                          2.2.2. Connectivity
                          2.2.3. End-use
                      2.3. Competitive Insights
Chapter 3. U.S. Continuous glucose monitoring devices Market Variables, Trends, & Scope
                      3.1. Market Lineage Outlook
                          3.1.1. Parent market outlook
                          3.1.2. Related/ancillary market outlook
                      3.2. Market Dynamics
                      3.3. Market Driver Analysis
                      3.4. Market Restraint Analysis
                      3.5. Industry Analysis - Porter’s Five Forces
                          3.5.1. Supplier power
                          3.5.2. Buyer power
                          3.5.3. Substitution threat
                          3.5.4. Threat of new entrant
                          3.5.5. Competitive rivalry
                      3.6. PESTEL Analysis
                          3.6.1. Political landscape
                          3.6.2. Technological landscape
                          3.6.3. Economic Landscape
Chapter 4. U.S. Continuous glucose monitoring devices Market Component Estimates & Trend Analysis
                      4.1. U.S. Continuous Glucose Monitoring Devices Component Model Dashboard
                      4.2. U.S. Continuous Glucose Monitoring Devices Component Movement Analysis
                      4.3. Transmitters
                          4.3.1. Transmitters market estimates and forecasts, 2018 - 2030 (USD Million)
                      4.4. Sensors
                          4.4.1. Sensors market estimates and forecasts, 2018 - 2030 (USD Million)
                      4.5. Receivers
                          4.5.1. Receivers market estimates and forecasts, 2018 - 2030 (USD Million)
Chapter 5. U.S. Continuous Glucose Monitoring Devices Market Connectivity Estimates & Trend Analysis
                      5.1. U.S. Continuous Glucose Monitoring Devices Component Model Dashboard
                     5.2. U.S. Continuous Glucose Monitoring Devices Component Movement Analysis
                      5.3. Bluetooth
                          5.3.1. Bluetooth Market, 2018 - 2030 (USD Million)
                      5.4. 4G
                          5.4.1. 4G Market, 2018 - 2030 (USD Million)
Chapter 6. U.S. Continuous Glucose Monitoring Devices Market End-use Estimates & Trend Analysis
                     6.1. U.S. Continuous Glucose Monitoring Devices Market End-use Model Dashboard
                     6.2. U.S. Continuous Glucose Monitoring Devices Market End-use Movement Analysis
                      6.3. Hospitals
                          6.3.1. Hospitals Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                      6.4. Homecare
                          6.4.1. Homecare Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                      6.5. Others
                          6.5.1. Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 7. Competitive Landscape
                      7.1. Recent Developments & Impact Analysis, By Key Market Participants
                      7.2. Company/Competition Categorization
                          7.2.1. Vendor Landscape
                          7.2.2. List of key distributors and channel partners
                          7.2.3. Key customers
                          7.2.4. Key company market share analysis, 2023
                          7.2.5. Dexcom, Inc.
                              7.2.5.1. Company overview
                              7.2.5.2. Financial performance
                              7.2.5.3. Product benchmarking
                              7.2.5.4. Strategic initiatives
                          7.2.6. Abbott
                              7.2.6.1. Company overview
                              7.2.6.2. Financial performance
                              7.2.6.3. Product benchmarking
                              7.2.6.4. Strategic initiatives
                          7.2.7. Senseonics Holdings, Inc.
                              7.2.7.1. Company overview
                              7.2.7.2. Financial performance
                              7.2.7.3. Product benchmarking
                              7.2.7.4. Strategic initiatives
                          7.2.8. Signos, Inc.
                              7.2.8.1. Company overview
                              7.2.8.2. Financial performance
                              7.2.8.3. Product benchmarking
                              7.2.8.4. Strategic initiatives
                          7.2.9. Ambrosia Systems
                              7.2.9.1. Company overview
                              7.2.9.2. Financial performance
                              7.2.9.3. Product benchmarking
                              7.2.9.4. Strategic initiatives
                          7.2.10. Levels
                              7.2.10.1. Company Overview
                              7.2.10.2. Financial performance
                              7.2.10.3. Product benchmarking
                              7.2.10.4. Strategic initiatives
                          7.2.11. Pops Diabetes Care, Inc.
                              7.2.11.1. Company Overview
                              7.2.11.2. Financial performance
                              7.2.11.3. Product benchmarking
                              7.2.11.4. Strategic initiatives
                          7.2.12. Beta Bionics, Inc.
                              7.2.12.1. Company Overview
                              7.2.12.2. Financial performance
                              7.2.12.3. Product benchmarking
                              7.2.12.4. Strategic initiatives
                          7.2.13. Diatech Diabetes, Inc.
                              7.2.13.1. Company Overview
                              7.2.13.2. Financial performance
                              7.2.13.3. Product benchmarking
                              7.2.13.4. Strategic initiatives
                          7.2.14. Phillips-Medisize
                              7.2.14.1. Company Overview
                              7.2.14.2. Financial performance
                              7.2.14.3. Product benchmarking
                              7.2.14.4. Strategic initiatives


List of Tables

Table 1. List of abbreviations
Table 2. U.S. Blood Pressure Monitoring, By Component, 2018 - 2030 (USD Billion)
Table 3. U.S. Blood Pressure Monitoring, By Connectivity, 2018 - 2030 (USD Billion)
Table 4. U.S. Blood Pressure Monitoring, By End-use, 2018 - 2030 (USD Billion)


List of Figures

Fig. 1 Market Research Process
Fig. 2 Information Procurement
Fig. 3 Primary Research Pattern
Fig. 4 Market Research Approaches
Fig. 5 Value Chain-Based Sizing & Forecasting
Fig. 6 Market Formulation & Validation
Fig. 7 Continuous glucose monitoring devices Market Segmentation
Fig. 8 Market Driver Relevance Analysis (Current & Future Impact)
Fig. 9 Market Restraint Relevance Analysis (Current & Future Impact)
Fig. 10 Market Challenge Relevance Analysis (Current & Future Impact)
Fig. 11 Penetration & Growth Prospect Mapping
Fig. 12 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
Fig. 13 Porter’s Five Forces Analysis
Fig. 14 U.S. Continuous glucose monitoring devices Market: Component outlook and key takeaways
Fig. 15 U.S. Continuous glucose monitoring devices Market: Component movement analysis & market share 2023 & 2030
Fig. 16 Sensors market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 17 Transmitters market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 18 Receivers market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 19 U.S. Continuous Glucose Monitoring Devices Market: Connectivity outlook and key takeaways
Fig. 20 U.S. Continuous Glucose Monitoring Devices Market: Connectivity movement analysis & market share
Fig. 21 Bluetooth market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 22 4G market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 23 U.S. Continuous glucose monitoring devices Market: End-use outlook and key takeaways
Fig. 24 U.S. Continuous glucose monitoring devices Market: End-use movement analysis & market share
Fig. 25 Hospitals market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 26 Homecare market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 27 Others market estimates and forecast, 2018 - 2030 (USD Million)

What questions do you have? Get quick response from our industry experts. Request a Free Consultation
pdf

GET A FREE SAMPLE

bck

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

cog

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

Contact us now to get our best pricing.

esomar icon

ESOMAR certified & member

ISO

ISO Certified

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.

great place to work icon